Transition Therapeutics Asset Utilization:
0.2686 for Dec. 31, 2012Transition Therapeutics Historical Asset Utilization Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 0.2686 |
| Sept. 30, 2012 | 0.2536 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| Dec. 31, 2011 | 0.00 |
| Sept. 30, 2011 | 0.2085 |
| June 30, 2011 | 0.2309 |
| March 31, 2011 | 0.2266 |
| Dec. 31, 2010 | 0.2551 |
| Sept. 30, 2010 | 0.0964 |
| June 30, 2010 | 0.0799 |
| March 31, 2010 | 0.101 |
| Dec. 31, 2009 | 0.0558 |
| Sept. 30, 2009 | 0.0368 |
| June 30, 2009 | 0.029 |
| March 31, 2009 | -0.0006 |
| Dec. 31, 2008 | -0.0006 |
| Sept. 30, 2008 | 0.0175 |
| June 30, 2008 | 0.0179 |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
About Asset Utilization
The asset utilization ratio calculates the total revenue earned for every dollar of assets a company owns.
For example, with an asset utilization ratio of 52%, a company earned $.52 for each dollar of assets held by the company. An increasing asset utilization means the company is being more efficient with each dollar of assets it has.
This ratio is frequently used to compare a company's efficiency over time.
Learn More
TTHI Asset Utilization Benchmarks
| Companies | |
|---|---|
| Elan | -0.1736 |
| ARCA biopharma | 0.00 |
| Bioline Rx | 0.00 |
TTHI Asset Utilization Rankings
| Overall |
57th percentile 3443 of 8007 |
| Sector |
43rd percentile 389 of 685 in Healthcare |
| Industry |
70th percentile 73 of 248 in Biotechnology |
TTHI Asset Utilization Range, Past 5 Years
| Minimum | -0.0006 | Dec 2008 |
| Maximum | 0.2686 | Dec 2012 |
| Average | 0.0988 |
